Publication Name	World Journal of Immunology
Manuscript ID	29766
Country	United Kingdom

Received	2016-08-27 13:52
Peer-Review Started	2016-08-29 15:00
To Make the First Decision	2016-09-27 17:25
Return for Revision	2016-10-08 20:56
Revised	2016-10-16 19:09
Second Decision	2016-10-21 18:32
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-10-27 17:11
Articles in Press	2016-10-27 17:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-11-21 08:48
Publish the Manuscript Online	2016-11-24 14:38

ISSN	2219-2824 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Immunology
Manuscript Type	Editorial
Article Title	Myeloid derived suppressor cells in breast cancer: A novel therapeutic target?
Manuscript Source	Invited Manuscript
All Author List	Rebekah M Weston and Cordula M Stover
Funding Agency and Grant Number
Corresponding Author	Cordula M Stover, PhD, Associate Professor, Department of Infection, Immunity and Inflammation, University of Leicester, Maurice Shock Medical Sciences Building, University Road, Leicester LE1 9HN, United Kingdom. cms13@le.ac.uk
Key Words	Breast cancer; Immune cells; Treatment; Suppression; Survival
Core Tip	Breast cancer is the most common cancer among women in the United Kingdom; there were 44540 new cases of invasive carcinoma in 2013. The incidence rate is 169.8:100000, an increase of 5.5% in 10 years. Despite significant advances in the detection and treatment of breast cancer, breast cancer still results in 11600 deaths a year; the second highest number of cancer deaths in women. With increased appreciation of the sustaining importance of cells in the tumour microenvironment, in particular myeloid derived suppressor cells, their targeting is being considered as a novel treatment approach.
Publish Date	2016-11-24 14:38
Citation	Weston RM, Stover CM. Myeloid derived suppressor cells in breast cancer: A novel therapeutic target? World J Immunol 2015; 6(3): 119-125
URL	http://www.wjgnet.com/2219-2824/full/v6/i3/119.htm
DOI	http://dx.doi.org/10.5411/wji.v6.i3.119

Full Article (PDF)	WJI-6-119.pdf
Full Article (Word)	WJI-6-119.doc
Manuscript File	29766-Review.docx
Answering Reviewers	29766-Answering reviewers.pdf
Audio Core Tip	29766-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	29766-Conflict-of-interest statement.pdf
Copyright License Agreement	29766-Copyright assignment.pdf
Peer-review Report	29766-Peer-review(s).pdf
Scientific Misconduct Check	29766-Scientific misconduct check.pdf
Scientific Editor Work List	29766-Scientific editor work list.pdf